Nucl Med Commun
April 2012
Objective: The aim of this prospective study was to investigate the role of 18F-fluorodeoxyglucose (18F-FDG) PET/CT in the diagnosis of recurrent intra-abdominal cancer in patients with increased tumor markers and negative findings on conventional imaging studies.
Methods: Seventy-three patients (30 men; age 61.1 ± 11.